ObvioHealth announces strategic investment by Guardant Health to accelerate deployment of oncology clinical trials globally
- Written by PR Newswire
SINGAPORE, July 25, 2024 /PRNewswire/ -- ObvioHealth, a global digital clinical trials company, announces a new strategic investment by Guardant Health, Inc., a leading precision oncology company offering liquid and tissue biopsy tests across the cancer research and care continuum. The alliance strengthens ObvioHealth's domain expertise in...













